{"id":2247,"date":"2017-12-19T16:49:20","date_gmt":"2017-12-19T16:49:20","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=33538"},"modified":"2017-12-19T16:49:20","modified_gmt":"2017-12-19T16:49:20","slug":"international-publications-spotlight-mjnas-influence-u-n-s-global-cbd-policy-announcement","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/12\/19\/international-publications-spotlight-mjnas-influence-u-n-s-global-cbd-policy-announcement\/","title":{"rendered":"International Publications Spotlight MJNA\u2019s Influence on U.N.\u2019s Global CBD Policy Announcement"},"content":{"rendered":"

Following the WHO\u2019s announcement of its stance that CBD not be considered a drug, several news reports covering the event highlighted MJNA\u2019s role in the organization\u2019s decision.<\/span><\/i><\/p>\n

Several international news publications covering last week\u2019s World Health Organization <\/span>announcement<\/span><\/a> of its recommendation that cannabidiol (<\/span>CBD<\/span><\/a>) not be subject to international drug scheduling specifically highlighted the impact of Medical Marijuana, Inc. Executive Raul Elizalde.<\/span><\/p>\n

Raul Addresses WHO Committee about CBD at United Nations<\/b><\/h2>\n

Raul, President of Medical Marijuana, Inc. subsidiary HempMeds\u00ae Mexico, was<\/span> invited to speak about CBD<\/span><\/a> at the WHO\u2019s Thirty-Ninth meeting of the Expert Committee on Drug Dependence in Geneva, Switzerland in November. The ECDD was reevaluating its international regulations of 16 substances, including CBD, a cannabis-derived, non-psychoactive compound that interacts with our naturally occurring systems.<\/span><\/p>\n

On behalf of MJNA\u2019s family of companies, Raul spoke to the ECDD about the benefits of CBD and encouraged the special committee to classify the non-psychoactive compound as a nutritional supplement and food rather than a drug. The special committee\u2019s recommendation regarding the regulation of CBD is likely to have positive worldwide implications on legal access.<\/span><\/p>\n

MJNA’s #RaulWHO campaign followed Raul during his journey to Geneva. Through the <\/span>#RaulWHO page<\/span><\/a>, those concerned about the future of CBD could keep up with regular announcements and personal streaming video updates from Raul.<\/span><\/p>\n

Raul\u2019s Impact on CBD Decision Garners International News Coverage<\/b><\/h2>\n

Raul\u2019s incredible efforts and his influence on the WHO special committee\u2019s recommendation were covered in international media outlets such as the following:<\/span><\/p>\n